Would the elderly be better off if they were given more placebos?

Geriatrics and Gerontology International

Volumn 10, Issue 2, 2010, Pages 131-137

  Cherniack, E Paul ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Medication; Placebo effect; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; DOPAMINE; ENDORPHIN; ESCITALOPRAM; FLUOXETINE; KETOROLAC; NALOXONE; PARACETAMOL; PLACEBO;

ACUPUNCTURE ANALGESIA; ADVERSE OUTCOME; ALTERNATIVE MEDICINE; BRAIN DEPTH STIMULATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONDITIONING; DEPRESSION; DOCTOR PATIENT RELATION; DOPAMINE RELEASE; ELDERLY CARE; EVIDENCE BASED MEDICINE; HEADACHE; HUMAN; MEDICAL ETHICS; MILIEU THERAPY; OSTEOARTHRITIS; PAIN; PARKINSON DISEASE; PATIENT SATISFACTION; PLACEBO EFFECT; PRIORITY JOURNAL; REVIEW; REWARD; SEROTONINERGIC SYSTEM; SPRAIN;

AGED, 80 AND OVER; ETHICS, RESEARCH; HUMANS; PHYSICIAN-PATIENT RELATIONS; PLACEBO EFFECT; PLACEBOS;

EID: 77952529743     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2009.00580.x     Document Type: Review

References (62)

1. Ernst E. Placebo: new insights into an old enigma. Drug Discov Today 2007, 12:413-418.
2. Alexopoulos GS, Kanellopoulos D, Murphy C, Gunning-Dixon F, Katz R, Heo M. Placebo response and antidepressant response. Am J Geriatr Psychiatry 2007, 15:149-158.
3. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002, 287:1840-1847.
4. Mayberg HS, Silva JA, Brannan SK. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002, 159:728-737.
5. de la Fuente-Fernandez R, Schulzer M, Stoessl AJ. The placebo effect in neurological disorders. Lancet Neurol 2002, 1:85-91.
6. De La Fuente-Fernandez R, Stoessl AJ. The biochemical bases for reward. Implications for the placebo effect. Eval Health Prof 2002, 25:387-398.
7. Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol 2008, 48:33-60.
8. Lidstone SC, De La Fuente-Fernandez R, Stoessl AJ. The placebo response as a reward mechanism. Semin Pain Med 2005, 3:37-42.
9. Goetz CG, Wuu J, McDermott MP. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord 2008, 23:690-699.
10. Mercado R, Constantoyannis C, Mandat T. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation. Mov Disord 2006, 21:1457-1461.
11. Finniss DG, Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain 2005, 114:3-6.
12. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001, 344:1594-1602.
13. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008, 59:565-590.
14. Moerman DE, Harrington A. Making space for the placebo effect in pain medicine. Semin Pain Med 2005, 3:2-6.
15. Evans E, Hoyle C. The comparative value of drugs used in the continuous treatment of angina pectoris. Q J Med 1933, 2:311-338.
16. Dimond EG, Kittle CF, Crockett JE. Comparison of internal mammary artery ligation and sham operation for angina pectoris. Am J Cardiol 1960, 5:483-486.
17. Amsterdam EA, Wolfson S, Gorlin R. New aspects of the placebo response in angina pectoris. Am J Cardiol 1969, 24:305-306.
18. Bienenfeld L, Frishman W, Glasser SP. The placebo effect in cardiovascular disease. Am Heart J 1996, 132:1207-1221.
19. Wager TD. The neural bases of placebo effects in anticipation and pain. Semin Pain Med 2005, 22-30.
20. Stewart-Williams S. The placebo puzzle: putting together the pieces. Health Psychol 2004, 23:198-206.
21. Benedetti F, Amanzio M, Baldi S, Casadio C, Maggi G. Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur J Neurosci 1999, 11:625-631.
22. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003, 23:4315-4323.
23. Koshi EB, Short CA. Placebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Pract 2007, 7:4-20.
24. Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med 2002, 136:471-476.
25. Waber RL, Shiv B, Carmon Z, Ariely D. Commercial features of placebo and therapeutic efficacy. JAMA 2008, 299:1016-1017.
26. Branthwaite A, Cooper P. Analgesic effects of branding in treatment of headaches. Br Med J (Clin Res Ed) 1981, 282:1576-1578.
27. Buckalew LW, Coffield KE. An investigation of drug expectancy as a function of capsule color and size and preparation form. J Clin Psychopharmacol 1982, 2:245-248.
28. de Craen AJ, Moerman DE, Heisterkamp SH, Tytgat GN, Tijssen JG, Kleijnen J. Placebo effect in the treatment of duodenal ulcer. Br J Clin Pharmacol 1999, 48:853-860.
29. de Craen AJ, Tijssen JG, de Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 2000, 247:183-188.
30. Walach H. The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap. J Altern Complement Med 2001, 7:213-218.
31. Manheimer E, Linde K, Lao L, Bouter LM, Berman BM. Meta-analysis: acupuncture for osteoarthritis of the knee. Ann Intern Med 2007, 146:868-877.
32. White A, Foster NE, Cummings M, Barlas P. Acupuncture treatment for chronic knee pain: a systematic review. Rheumatology (Oxford) 2007, 46:384-390.
33. Packer M. The placebo effect in heart failure. Am Heart J 1990, 120:1579-1582.
34. Archer TP, Leier CV. Placebo treatment in congestive heart failure. Cardiology 1992, 81:125-133.
35. Meissner K, Distel H, Mitzdorf U. Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials. BMC Med 2007, 5:3.
36. Asmar R, Safar M, Queneau P. Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. Am J Hypertens 2001, 14:546-552.
37. Mancia G, Omboni S, Parati G, Ravogli A, Villani A, Zanchetti A. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995, 8:311-315.
38. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994, 331:394-398.
39. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med 2000, 133:455-463.
40. De Deyn PP, D'Hooge R. Placebos in clinical practice and research. J Med Ethics 1996, 22:140-146.
41. Emanuel EJ, Miller FG. The ethics of placebo-controlled trials - a middle ground. N Engl J Med 2001, 345:915-919.
42. Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ann Intern Med 2000, 133:464-470.
43. Simon R. Are placebo-controlled clinical trials ethical or needed when alternative treatment exists? Ann Intern Med 2000, 133:474-475.
44. Kinnaert P. [Placebo and placebo effects (second part): ethical aspects]. Rev Med Brux 2007, 28:39-44.
45. Kaptchuk TJ. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Ann Intern Med 2002, 136:817-825.
46. Ness J, Cirillo DJ, Weir DR, Nisly NL, Wallace RB. Use of complementary medicine in older Americans: results from the Health and Retirement Study. Gerontologist 2005, 45:516-524.
47. Gryll SL, Katahn M. Situational factors contributing to the placebos effect. Psychopharmacology (Berl) 1978, 57:253-261.
48. Sox HC, Margulies I, Sox CH. Psychologically mediated effects of diagnostic tests. Ann Intern Med 1981, 95:680-685.
49. Sherman R, Hickner J. Academic physicians use placebos in clinical practice and believe in the mind-body connection. J Gen Int Med 2006, 23:7-10.
50. Hrobjartsson A, Norup M. The use of placebo interventions in medical practice - a national questionnaire survey of Danish clinicians. Eval Health Prof 2003, 26:153-165.
51. Nitzan U, Lichtenberg P. Questionnaire survey on use of placebo. BMJ 2004, 329:944-946.
52. Bostick NA, Sade R, Levine MA, Stewart DM. Placebo use in clinical practice: report of the American Medical Association Council on Ethical and Judicial Affairs. J Clin Ethics 2008, 19:58-61.
53. Hrobjartsson A. Clinical placebo interventions are unethical, unnecessary, and unprofessional. J Clin Ethics 2008, 19:66-69.
54. Park LC, Covi L. Nonblind placebo trial: an exploration of neurotic patients' responses to placebo when its inert content is disclosed. Arch Gen Psychiatry 1965, 12:36-45.
55. Holmes DS, Bennett DH. Experiments to answer questions raised by the use of deception in psychological research. I. Role playing as an alternative to deception. II. Effectiveness of debriefing after a deception. 3. Effect of informed consent on deception. J Pers Soc Psychol 1974, 29:358-367.
56. Sherman R, Hickner J. Placebos: current clinical realities. J Clin Ethics 2008, 19:62-65.
57. Ernst E. Placebo, deceit and complementary/alternative medicine. Climacteric 2007, 10:85-87.
58. Lim EC-H, Wilder-Smith EPV, Ong BKC, Seet RCS. Is there a place for placebos in clinical practice? Int Med J 2005, 35:734-735.
59. Lim EC, Seet RC. What is the place for placebo in the management of psychogenic disease? J R Soc Med 2007, 100:60-61.
60. Kaptchuk TJ, Kelley JM. Do " placebo responders" exist? Contemp Clin Trials 2008, 29:587-595.
61. Witt C, Brinkhaus B, Jena S. Acupuncture in patients with osteoarthritis of the knee: a randomised trial. Lancet 2005, 366:136-143.
62. Arita H, Hayashida M, Hanaoka K. Pain control for elderly patients in Japan. Geriatr Gerontol Int 2004, 4:S239-S241.